FY24 Daybue Guidance Reaffirmed After a Weak 1Q Performance_老虎社区_美港股上老虎

FY24 Daybue Guidance Reaffirmed After a Weak 1Q Performance

Smartkarma
2024-05-09

⬆ $Acadia Pharmaceuticals(ACAD)$ - Daybue revenues came in at $75.9M (-13% q/q) vs. our $71.5M and consensus’ $78M estimates. The sequential decline in sales was driven by a (1)...

Continue reading on Smartkarma:- https://www.smartkarma.com/insights/fy24-daybue-guidance-reaffirmed-after-a-weak-1q-performance?utm_source=tiger_community

By CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community

On Acadia Pharmaceuticals (ACAD):- https://www.smartkarma.com/entities/acadia-pharmaceuticals-inc?utm_source=tiger_community

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":303964098715792,"tweetId":"303964098715792","gmtCreate":1715217491000,"gmtModify":1715220275291,"author":{"id":4103332230805300,"idStr":"4103332230805300","authorId":4103332230805300,"authorIdStr":"4103332230805300","name":"Smartkarma","avatar":"https://static.tigerbbs.com/bb92df7ff435380d798b36afa44a5c07","vip":5,"userType":5,"introduction":"Smartkarma官方账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":352,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"FY24 Daybue Guidance Reaffirmed After a Weak 1Q Performance","html":"<html><head></head><body> \n⬆ $Acadia Pharmaceuticals(ACAD)$ - Daybue revenues came in at $75.9M (-13% q/q) vs. our $71.5M and consensus’ $78M estimates. The sequential decline in sales was driven by a (1)...\n \nContinue reading on Smartkarma:- https://www.smartkarma.com/insights/fy24-daybue-guidance-reaffirmed-after-a-weak-1q-performance?utm_source=tiger_community\nBy CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community\nOn Acadia Pharmaceuticals (ACAD):- https://www.smartkarma.com/entities/acadia-pharmaceuticals-inc?utm_source=tiger_community</body></html>","htmlText":"<html><head></head><body> \n⬆ $Acadia Pharmaceuticals(ACAD)$ - Daybue revenues came in at $75.9M (-13% q/q) vs. our $71.5M and consensus’ $78M estimates. The sequential decline in sales was driven by a (1)...\n \nContinue reading on Smartkarma:- https://www.smartkarma.com/insights/fy24-daybue-guidance-reaffirmed-after-a-weak-1q-performance?utm_source=tiger_community\nBy CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community\nOn Acadia Pharmaceuticals (ACAD):- https://www.smartkarma.com/entities/acadia-pharmaceuticals-inc?utm_source=tiger_community</body></html>","text":"⬆ $Acadia Pharmaceuticals(ACAD)$ - Daybue revenues came in at $75.9M (-13% q/q) vs. our $71.5M and consensus’ $78M estimates. The sequential decline in sales was driven by a (1)... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/fy24-daybue-guidance-reaffirmed-after-a-weak-1q-performance?utm_source=tiger_community By CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community On Acadia Pharmaceuticals (ACAD):- https://www.smartkarma.com/entities/acadia-pharmaceuticals-inc?utm_source=tiger_community","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/303964098715792","repostId":0,"isVote":1,"tweetType":1,"viewCount":27953,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["LU2065171311.SGD","LU2065169927.USD","ACAD","LU2065170008.USD","LU2065171402.SGD"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":550,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}